Omar Ishrak - Oct 23, 2023 Form 4 Insider Report for ALLURION TECHNOLOGIES, INC. (ALUR)

Role
Director
Signature
/s/ Jennifer Ausrotas, attorney-in-fact
Stock symbol
ALUR
Transactions as of
Oct 23, 2023
Transactions value $
$0
Form type
4
Date filed
10/25/2023, 04:53 PM
Previous filing
Aug 10, 2023
Next filing
Nov 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALUR Common Stock Award $0 +45.2K $0.00 45.2K Oct 23, 2023 Direct F1
holding ALUR Common Stock 710K Oct 23, 2023 See footnote F2
holding ALUR Common Stock 3.26M Oct 23, 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this transaction represent an initial, one-time grant of Restricted Stock Units ("RSUs") issued pursuant to the Issuer's non-employee director compensation policy and the Allurion Technologies, Inc. 2023 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in equal annual installments over three years from October 23, 2023, subject to the Reporting Person's continued service as a director of the Issuer on each such vesting date.
F2 Shares held by Omar & Helen Ishrak Living Trust ("Ishrak Trust"). The Reporting Person disclaims Section 16 beneficial ownership of the securities held by the Ishrak Trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or any other purpose.
F3 The shares are held directly by Compute Health Sponsor LLC ("Compute Health"). The Reporting Person is a managing member of Compute Health and disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission that the Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act.